About Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency
Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency is a rare disease catalogued by Orphanet (ORPHA:314376). It is associated with the GUCY2C gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency trials.
Search ClinicalTrials.gov for "Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency" or filter by Orphanet code ORPHA:314376 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency. Updated daily.